8-K: Liquidia Corporation Appoints Dana Boyle as Chief Accounting Officer, Details Compensation Package

Liquidia Corporation announced the appointment of Dana Boyle as its new Chief Accounting Officer, effective July 1, 2025, along with her compensation and severance arrangements.

Summary

• Dana Boyle was appointed as Liquidia Corporation's Chief Accounting Officer, effective July 1, 2025.
• Ms. Boyle, age 41, previously served as the company's Senior Vice President, Finance and Controller since January 2021.
• Her compensation includes an annual base salary of $425,000 and eligibility for a discretionary annual cash bonus of 50% of her base salary.
• She was granted Restricted Stock Units (RSUs) valued at $300,000, which will vest 25% on July 11, 2026, with the remainder vesting in equal quarterly installments over the subsequent three years.
• Ms. Boyle is eligible for severance benefits, including 12 months of base salary and COBRA premiums, upon an Involuntary Termination outside a Change in Control Period.
• In the event of an Involuntary Termination within a Change in Control Period, she is eligible for 12 months of base salary and target annual incentive, 100% vesting of unvested equity, and a lump sum COBRA payment.

Sentiment

Score: 7

Explanation: The document reflects a positive and standard corporate action, strengthening the company's financial leadership with an experienced internal promotion and a well-defined compensation package. No negative or concerning information is present.

Positives

• Appointment of an experienced internal candidate, Dana Boyle, to a key financial leadership role as Chief Accounting Officer.
• Ms. Boyle's extensive background in biotech and pharmaceutical financial roles, including her CPA license, strengthens the company's financial oversight.
• The structured compensation package, including base salary, bonus eligibility, and RSU grants, aligns her incentives with long-term company performance.

Future Outlook

The document outlines the vesting schedule for Ms. Boyle's restricted stock units, with 25% vesting on July 11, 2026, and the balance vesting in equal quarterly installments over the subsequent three years, contingent on her continuous employment.

Industry Context

The appointment of a Chief Accounting Officer is a standard corporate governance practice for publicly traded companies, particularly in the biotech and pharmaceutical sectors, ensuring robust financial reporting and compliance. This move reflects Liquidia's commitment to strengthening its internal financial leadership.

Comparison to Industry Standards

• The compensation structure, including base salary, performance-based bonus, and equity grants, is typical for a Chief Accounting Officer role in a publicly traded biotech company of Liquidia's size and stage.
• Severance provisions, particularly those enhanced during a change in control period, are common in executive compensation packages across the industry to provide stability and incentivize retention during transitions.

Management Changes

Stakeholder Impact

• Shareholders: The appointment of an experienced Chief Accounting Officer can enhance confidence in the company's financial reporting and internal controls.
• Employees: The promotion of an internal candidate like Ms. Boyle can signal opportunities for career advancement within the company.

Next Steps

• Ms. Boyle's Restricted Stock Units will begin vesting on July 11, 2026.
• Subsequent RSU vesting will occur in equal quarterly installments over the three years following the initial vesting date.

Key Dates

Keywords

Liquidia Corporation, Chief Accounting Officer, Dana Boyle, Executive Appointment, Compensation, Restricted Stock Units, Severance Plan, Corporate Governance, Biotech, Pharmaceutical